indisetron

This page covers all indisetron drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting 5-hydroxytryptamine receptor 3A.

Targets

5-hydroxytryptamine receptor 3A

Phase 2 pipeline (1)

• Sinseron · Neuroscience
  Sinseron works by binding to the 5-hydroxytryptamine receptor 3A, which is involved in various physiological processes.